| ID Source | ID |
|---|---|
| PubMed CID | 193312 |
| SCHEMBL ID | 12160292 |
| MeSH ID | M0104806 |
| Synonym |
|---|
| difructose anhydride iv |
| SCHEMBL12160292 |
| di-beta-d-fructofuranose 2,6':6,2'-dianhydride |
| di-d-fructofuranaose 2,6'-6,2' dianhydride |
| 1,7-bis(hydroxymethyl)-2,8,13,14-tetraoxatricyclo[8.2.1.14,7]tetradecane-5,6,11,12-tetrol |
Difructose anhydride IV (DFA IV) is a cyclic disaccharide consisting of two fructose residues. It is obtained from levan conversion with levan fructotransferase (LFTase)
| Excerpt | Reference | Relevance |
|---|---|---|
| "Difructose anhydride IV (DFA IV) is a cyclic disaccharide consisting of two fructose residues, which is obtained from levan conversion with levan fructotransferase (LFTase) and rarely found in nature as a low-calorie sugar substitute. " | ( Recent advances on the difructose anhydride IV preparation from levan conversion. Hang, H, 2017) | 2.21 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.15) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 3 (20.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 12 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||